Your browser doesn't support javascript.
loading
ZVex™, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities.
Leleux, Jardin A; Albershardt, Tina C; Parsons, Andrea J; Ter Meulen, Jan; Berglund, Peter.
Afiliación
  • Leleux JA; Immune Design Corp., Seattle, WA, A Wholly Owned Subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: jardin.leleux@gmail.com.
  • Albershardt TC; Immune Design Corp., Seattle, WA, A Wholly Owned Subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
  • Parsons AJ; Immune Design Corp., Seattle, WA, A Wholly Owned Subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
  • Ter Meulen J; Immune Design Corp., Seattle, WA, A Wholly Owned Subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
  • Berglund P; Immune Design Corp., Seattle, WA, A Wholly Owned Subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
Vaccine ; 38(41): 6367-6373, 2020 09 22.
Article en En | MEDLINE | ID: mdl-32828576
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Vacunas de ADN Límite: Animals Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Vacunas de ADN Límite: Animals Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article